PAPER Choquet D, Opazo P, Zhang H

AMPA receptor diffusional trapping machinery as an early therapeutic target in neurodegenerative and neuropsychiatric disorders.

Transl Neurodegener. 2025 Feb 11;14(1):8. PubMed.

PAPER Pérez-Millan A, Lal-Trehan Estrada UM, Falgàs N, Guillén N, Borrego-Écija S, Juncà-Parella J, Bosch B, Tort-Merino A, Sarto J, Augé JM, Antonell A, Bargalló N, Ruiz-García R, Naranjo L, Balasa M, Lladó A, Sala-Llonch R, Sánchez-Valle R

The Cortical Asymmetry Index for subtyping dementia patients.

Eur Radiol. 2025 Feb 11; Epub 2025 Feb 11 PubMed.

PAPER Yarbro JM, Han X, Dasgupta A, Yang K, Liu D, Shrestha HK, Zaman M, Wang Z, Yu K, Lee DG, Vanderwall D, Niu M, Sun H, Xie B, Chen PC, Jiao Y, Zhang X, Wu Z, Chepyala SR, Fu Y, Li Y, Yuan ZF, Wang X, Poudel S, Vagnerova B, He Q, Tang A, Ronaldson PT, Chang R, Yu G, Liu Y, Peng J

Human and mouse proteomics reveals the shared pathways in Alzheimer's disease and delayed protein turnover in the amyloidome.

Nat Commun. 2025 Feb 11;16(1):1533. PubMed.

PAPER Rob M, Yousef M, Lakshmanan AP, Mahboob A, Terranegra A, Chaari A

Microbial signatures and therapeutic strategies in neurodegenerative diseases.

Biomed Pharmacother. 2025 Mar;184:117905. Epub 2025 Feb 10 PubMed.

PAPER Tian B, Kang J, Zhong W

Feature screening for metric space-valued responses based on Fréchet regression with its applications.

Biometrics. 2025 Jan 7;81(1) PubMed.

PAPER Kaur M, Aran KR

Unraveling the role of Nrf2 in dopaminergic neurons: a review of oxidative stress and mitochondrial dysfunction in Parkinson's disease.

Metab Brain Dis. 2025 Feb 11;40(2):123. PubMed.

PAPER Naranjo L, Sarto J, Nos C, Alcolea D, Rodríguez-Baz I, Navalpotro-Gómez I, Fernández-Lebrero A, Bertrán-Recasens B, Erro ME, Pelayo-Negro AL, Esteve C, Fernández S, Massot-Tarrús A, Boltes A, Torrents A, Guanyabens N, Palomino-García A, Egri N, Lladó A, Balasa M, Romera MA, Antón MD, Couso RS, Sánchez-Valle R, Ruiz-García R, Spanish sCJD Study Group

Isolated CSF RT-QuIC positivity associates with a less aggressive disease course and decreased levels of neuronal/glial damage biomarkers in patients with sporadic Creutzfeldt-Jakob disease.

J Neurol. 2025 Feb 11;272(3):198. PubMed.

PAPER Grünblatt E, Yde Ohki CM, Schmitt-Böhrer GA, Riederer P, Walitza S

Exploring the interplay of glucose metabolism, insulin resistance, and neurodegenerative pathologies: insights from streptozotocin and hypoglycaemic in vitro models.

J Neural Transm (Vienna). 2025 Feb 11; Epub 2025 Feb 11 PubMed.

PAPER Patira R, Shahabadi AZ, Lopez O, Kofler J

aFTLD-U presenting with primary progressive aphasia suggestive of non-fluent type with apraxia of speech.

Neurocase. 2025 Feb 11;:1-4. Epub 2025 Feb 11 PubMed.

PAPER Jin L, Nie L, Deng Y, Khana GJ, He N

The Application of Polymeric Nanoparticles as Drug Delivery Carriers to Cells in Neurodegenerative Diseases.

Cell Prolif. 2025 Feb 11;:e13804. Epub 2025 Feb 11 PubMed.

PAPER Radin DP, Zhong S, Cerne R, Shoaib M, Smith JL, Witkin J, Lippa A

Preclinical Pharmacology of CX1837, a High-Impact Ampakine with an Improved Safety Margin: Implications for Treating Alzheimer's Disease and Ischemic Stroke.

Curr Alzheimer Res. 2025 Feb 10; Epub 2025 Feb 10 PubMed.

PAPER Mumtaz, Ahmed F, Rabbani SA, El-Tanani M, Najmi AK, Ali J, Khan MA

Tauopathy in AD: Therapeutic Potential of MARK-4.

Curr Alzheimer Res. 2025 Feb 10; Epub 2025 Feb 10 PubMed.

PAPER Cho Y, Lee J, Kim JS, Jeon Y, Han S, Cho H, Lee Y, Kim TK, Hong JM, Lee Y, Byun Y, Chae M, Park S, Palomera LF, Park SY, Kim H, Kim S, Kang S, Jee JG, An H, Yim JH, Kim SH, Jo DG

RA-PR058, a novel ramalin derivative, reduces BACE1 expression and phosphorylation of tau in Alzheimer's disease mouse models.

Anim Cells Syst (Seoul). 2025;29(1):122-134. Epub 2025 Feb 7 PubMed.

PAPER Ding J, Long Z, Liu Y, Wang M

Study on influencing factors of age-adjusted Charlson comorbidity index in patients with Alzheimer's disease based on machine learning model.

Front Med (Lausanne). 2025;12:1497662. Epub 2025 Jan 27 PubMed.

PAPER Silva-Llanes I, Madruga E, Martínez A, Lastres-Becker I

RIPK1 expression and inhibition in tauopathies: implications for neuroinflammation and neuroprotection.

Front Neurosci. 2024;18:1530809. Epub 2025 Jan 27 PubMed.